Evanson Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-566
| Closed | -$275K | – | 339 |
|
|
2025
Q1 | $275K | Hold |
566
| – | – | 0.02% | 254 |
|
|
2024
Q4 | $228K | Hold |
566
| – | – | 0.02% | 283 |
|
|
2024
Q3 | $263K | Hold |
566
| – | – | 0.02% | 267 |
|
|
2024
Q2 | $265K | Hold |
566
| – | – | 0.02% | 254 |
|
|
2024
Q1 | $237K | Sell |
566
-659
| -54% | -$276K | 0.02% | 272 |
|
|
2023
Q4 | $498K | Sell |
1,225
-146
| -11% | -$59.4K | 0.04% | 170 |
|
|
2023
Q3 | $477K | Hold |
1,371
| – | – | 0.04% | 169 |
|
|
2023
Q2 | $483K | Hold |
1,371
| – | – | 0.04% | 167 |
|
|
2023
Q1 | $432K | Buy |
+1,371
| New | +$432K | 0.04% | 174 |
|